Encyclopedia of Cancer

Editor/Author Schwab, Manfred
Publication Year: 2017
Publisher: Springer Science+Business Media

ISBN: 978-3-662-46875-3
Category: Health & Medicine - Medicine
Image Count: 1239
Book Status: Pending
Predicted Release Month: Sept 2019
Table of Contents

This work comprehensively describes etiological factors in the development , Progression and metastasis of human cancers, both for hematological malignancies and for solid Tumors.

Share this

Table of Contents

  • Preface to the Fourth Edition
  • Preface to the Third Edition
  • Preface to the Second Edition
  • Preface to the First Edition
  • Editors and Contributors
  • A
  • AAMP
  • AAV
  • ABC Drug-Transporters
  • ABCC Transporters
  • ABC-Transporters
  • Abraxas
  • Abscopal Effects
  • ABVD
  • Achneiform Rash
  • Actinic Keratosis
  • Activated Natural Killer Cells
  • Activation-Induced Cytidine Deaminase
  • Active Specific Immunization
  • Activin
  • Activin Receptors
  • Acute Lymphoblastic Leukemia
  • Acute Megakaryoblastic Leukemia
  • Acute Myeloid Leukemia
  • Acute Promyelocytic Leukemia
  • ADAM Molecules
  • ADAM17
  • Adaptive Immunity
  • Adaptor Proteins
  • Adducts to DNA
  • Adenocarcinoma
  • Adenoma
  • Adenopathy
  • Adenosine and Tumor Microenvironment
  • Adenovirus
  • Adherens Junctions
  • Adhesion
  • Adiponectin
  • Adipose Tumors
  • Adjuvant Chemoendocrine Therapy
  • Adjuvant Therapy
  • ADMET Screen
  • Adoptive Immunotherapy
  • Adoptive T-Cell Transfer
  • Adrenocortical Cancer
  • Adrenomedullin
  • Adriamycin
  • Adult Stem Cells
  • Adult T-Cell Leukemia
  • Aflatoxins
  • Aflibercept
  • Aggressive Fibromatosis in Children
  • Aging
  • Aging-Associated Inflammation
  • AIDS-Associated Malignancies
  • Akt Signal Transduction Pathway
  • Alcohol Consumption
  • Alcoholic Beverages Cancer Epidemiology
  • Alcoholic Pancreatitis
  • Aldehyde Dehydrogenases
  • ALK Protein
  • Alkylating Agents
  • Allele Imbalance
  • Allergy
  • Allogeneic Cell Therapy
  • Alpha-Fetoprotein
  • Alpha-Fetoprotein Diagnostics
  • Alu Elements
  • AME Transcription Factor
  • Amine Oxidases
  • Amphiregulin
  • Amplification
  • Amplified in Breast Cancer 1
  • Amrubicin
  • Anaplastic Large Cell Lymphoma
  • Anaplastic Lymphoma Kinase
  • Anchorage-Independent
  • Androgen Ablation Therapy
  • Androgen Receptor
  • Androgen-Independent Prostate Cancer (AIPC)
  • Aneuploidy
  • Angiogenesis
  • Angiogenin
  • Angiopoietins
  • Angiotensin II Signaling
  • Anoikis
  • Anoxia
  • Ansamycin Class of Natural Product Hsp90 Inhibitors
  • Anthracyclines
  • Antiangiogenesis
  • Antibody-Dependent Cellular Cytotoxicity
  • Antibody-Directed Enzyme Prodrug Therapy
  • Anti-Cancer Peptides
  • Antiglycolytics and Cancer
  • Anti-Her2/Neu Peptide Mimetic
  • Antihormonal Therapy
  • Antihormones
  • Anti-inflammatory Drugs
  • Antimitotic Drugs
  • Antioxidant Enzymes
  • Antisense DNA Therapy
  • Antiviral Defenses
  • Antizyme Inhibitor
  • AP-1
  • APAF-1 Signaling
  • APC Gene in Familial Adenomatous Polyposis
  • APC/β-Catenin Pathway
  • Apico-Basal Polarity
  • Apoptosis
  • Apoptosis Induction for Cancer Therapy
  • Appendiceal Epithelial Neoplasms
  • Aptamer Bioconjugates for Cancer Therapy
  • Arachidonic Acid Pathway
  • ARF Tumor Suppressor Protein
  • Arginine
  • Arginine-Depleting Enzyme Arginine Deiminase
  • Aromatase and Its Inhibitors
  • Aromatic Amine
  • Array CGH
  • Arrhenoblastoma
  • Arsenic
  • Artemisinin
  • Aryl Hydrocarbon Receptor
  • Arylamine N-Acetyltransferases
  • Asbestos
  • Ascites
  • Askin Tumor
  • Aspirin
  • Astrocytoma
  • Asymmetric Cell Division
  • ATM Protein
  • Aurora Kinases
  • Autoantibodies
  • Autocrine Signaling
  • Autoimmunity and Cancer
  • Autophagy
  • Autotaxin
  • 5-aza-2′ Deoxycytidine
  • B
  • Bacillus Calmette-Guérin
  • BARD1
  • Barrett Esophagus
  • Basal Cell Carcinoma
  • Basalioma
  • B-Cell Lymphoma
  • B-Cell Tumors
  • Bcl2
  • BCL3
  • BCL6 Translocations in B-Cell Tumors
  • BCR-ABL1
  • Beckwith-Wiedemann Syndrome
  • Beckwith-Wiedemann Syndrome Associated Childhood Tumors
  • Behcet Disease
  • Benign Prostate Hyperplasia
  • Benzene and Leukemia
  • Benzpyrene
  • Beta-Glucosidase
  • Betulinic Acid
  • Bevacizumab
  • Bid
  • BIK Proapoptotic Protein
  • Bile Acids
  • Bile Duct Neoplasms
  • Bin1
  • Bioavailability
  • Bioconjugate
  • Bioluminescence Imaging
  • Biomarkers in Detection of Cancer Risk Factors and in Chemoprevention
  • Biomonitoring
  • Birt-Hogg-Dubé Syndrome
  • Bispecific Antibodies
  • Bisphosphonates
  • Bladder Cancer
  • Bladder Cancer Molecular Therapy
  • Bladder Cancer Pathology
  • Blast Crisis
  • Bleomycin
  • Blood-Brain Barrier
  • Bloom Syndrome
  • Bone Loss Cancer Mediated
  • Bone Metastasis
  • Bone Tropism
  • Bone Tumors
  • BORIS
  • Bortezomib
  • Bovine Papillomavirus
  • Bowen Disease
  • Brachytherapy
  • BRaf-Signaling
  • BRAF Somatic Alterations
  • Brain Cancer Pathology
  • Brain Tumors
  • BRCA1/BRCA2 Germline Mutations and Breast Cancer Risk
  • Breast Cancer
  • Breast Cancer Antiestrogen Resistance
  • Breast Cancer Carcinogenesis
  • Breast Cancer Drug Resistance
  • Breast Cancer Epidemiology
  • Breast Cancer Familial Risk
  • Breast Cancer Immunotherapy
  • Breast Cancer Multifocality
  • Breast Cancer Multistep Development
  • Breast Cancer New Therapies: HER2, VEGF, and PARP as Targets
  • Breast Cancer Prognostic and Predictive Biomarkers
  • Breast Cancer Prognostic Biomarkers
  • Breast Cancer Stem Cells
  • Breast Cancer Susceptibility Genes
  • BRIT1 Gene
  • BRMS1
  • Bryostatin-1
  • Burkitt Lymphoma
  • Bystander Effect
  • C
  • Ca2+ Homeostasis
  • Cachexia
  • Cafe-Au-Lait Spots
  • Cajal Bodies
  • Calcitonin
  • Calcium-Binding Proteins
  • Calpain
  • Calreticulin
  • CAMTA1
  • Cancer
  • Cancer and Cadmium
  • Cancer Causes and Control
  • Cancer Epidemiology
  • Cancer Epigenetics
  • Cancer Germline Antigens
  • Cancer Stem Cells Targeted Drug Development
  • Cancer Stem-Like Cells
  • Cancer Vaccines
  • Cannabinoids
  • Carbon Metabolism
  • Carbonyl Metabolism
  • Carcinoembryonic Antigen
  • Carcinogen Metabolism
  • Carcinogenesis
  • Carcinoid
  • Carcinoid Tumors
  • Carcinoma In Situ
  • Carcinomatosis
  • Carcinosarcoma
  • Cardiac Tumors
  • Carney Complex
  • Carotenoids
  • Case Control Association Study
  • Caspase
  • Caspase-8
  • Caspase-Independent Apoptosis
  • Castrate-Resistant Prostate Cancer
  • Castration-Resistant Prostate Cancer
  • Cathepsin-D
  • Cathepsins
  • Caveolins
  • CBP/p300 Coactivators
  • CCCTC-Binding Factor
  • CD Antigens
  • CD26/DPPIV in Cancer Progression and Spread
  • CD44
  • CDCP1
  • CDKN2A
  • CDX2
  • CEA Gene Family
  • CEACAM1 Adhesion Molecule
  • Celastrol
  • Celecoxib
  • Cell Adhesion Molecules
  • Cell Biology
  • Cell Cycle Checkpoint
  • Centrosome
  • Ceramide
  • Cervical Cancers
  • Cetuximab
  • Chelators as Anti-Cancer Drugs
  • Chemical Carcinogenesis
  • Chemically Induced Cell Transformation
  • Chemoattraction
  • Chemokine Receptor CXCR4
  • Chemokines
  • Chemoprevention
  • Chemoprotectants
  • Chemoradiotherapy
  • Chemosensibilization
  • Chemotherapy
  • CHFR
  • Childhood Adrenocortical Carcinoma
  • Childhood Cancer
  • Childhood Cancer and Pediatric Cancer Predisposition Syndromes
  • Childhood Cancer and Treatment-Related Toxicities
  • Chimeric Antigen Receptor (CAR)
  • Chimeric Antigen Receptor on T Cells
  • Chinese Versus Western Medicine
  • Cholangiocarcinoma
  • Choline Kinase
  • Chorioallantoic Membrane
  • Chromatin Remodeling
  • Chromium Carcinogenesis
  • Chromophore-Assisted Laser Inactivation
  • Chromosomal Fluorescence In Situ Hybridization
  • Chromosomal Instability
  • Chromosomal Translocation t(8;21)
  • Chromosomal Translocations
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia
  • Chronic Obstructive Pulmonary Disease and Lung Cancer
  • Cip-Interacting Zinc Finger Protein 1 Ciz1
  • Circadian Clock Induction
  • Circulating Nucleic Acids
  • Circulating Tumor Cells
  • Cisplatin
  • CK2
  • Cladribine
  • Class II Tumor Suppressor Genes
  • Clinical Cancer Biomarkers
  • Clinical Trial
  • Clusterin
  • Coagulopathy
  • Coffee Consumption
  • Cohesins
  • Cohort Study
  • Colon Cancer Carcinogenesis in Human and in Experimental Animal Models
  • Colon Cancer Classification
  • Colon Cancer Genomic Pathways
  • Colon Cancer Molecular and Targeted Experimental Therapy
  • Colon Cancer Pathology of Hereditary Forms
  • Colorectal Cancer
  • Colorectal Cancer Chemoprevention
  • Colorectal Cancer Clinical Oncology
  • Colorectal Cancer Nutritional Carcinogenesis
  • Colorectal Cancer Pathology
  • Colorectal Cancer Premalignant Lesions
  • Colorectal Cancer Therapeutic Antibodies
  • Colorectal Cancer Vaccine Therapy
  • Combinatorial Cancer Therapy
  • Combinatorial Selection Methods
  • Comet Assay
  • Comparative Oncology
  • Complement-Dependent Cytotoxicity
  • Confocal Laser-Scanning Microscopy In Vivo
  • Conjugated Linolenic Acids
  • Connexins
  • Constitutive Androstane Receptor
  • Contact Normalization
  • Contralateral Breast Cancer
  • Convection-Enhanced Delivery
  • Cortactin
  • Cowden Syndrome
  • COX-2 in Colorectal Cancer
  • CpG Islands
  • Cripto-1
  • Crohn Colitis
  • Crohn Disease
  • Cryosurgery
  • Cryptotanshinone
  • Crypts
  • Cucurbitacin B
  • Cullin Ubiquitin E3 Ligases
  • Curcumin
  • Cushing Syndrome
  • Cutaneous Desmoplastic Melanoma
  • Cyclin D
  • Cyclin G-Associated Kinase
  • Cyclin-Dependent Kinases
  • Cyclins
  • Cyclooxygenase
  • Cyclophosphamide
  • Cylindromatosis
  • Cystatins
  • Cystic Fibrosis
  • Cystic Nephroma
  • Cytochalasin B
  • Cytochrome P450
  • Cytokine
  • Cytokine Receptor as the Target for Immunotherapy and Immunotoxin Therapy
  • Cytoskeleton
  • Cytotoxic T Cells
  • D
  • Dactinomycin
  • Daxx
  • Death Receptors
  • Decatenation G2 Checkpoint
  • Decay-Accelerating Factor
  • Decoy Receptor
  • Decoy Receptor 3
  • Deferasirox
  • Deleted in Malignant Brain Tumors 1
  • Deleted in Pancreatic Carcinoma Locus 4
  • Dendritic Cells
  • Dental Pulp Neoplasms
  • Desmoglein-2
  • Desmoid Tumor
  • Desmoplasia
  • Desmoplastic Small Round Cell Tumor
  • Desmosomes
  • Detoxification
  • Diabody
  • Diethylstilbestrol
  • Diffuse Large B-Cell Lymphoma
  • Dimethylfumarate
  • Dioxin
  • DLC1
  • DNA Damage
  • DNA Damage Response
  • DNA Damage Response Genes
  • DNA Damage Tolerance
  • DNA Damage-Induced Apoptosis
  • DNA Oxidation Damage
  • DNA Vaccination
  • Docetaxel
  • Dormancy
  • Doublecortin
  • Drug Delivery Systems for Cancer Treatment
  • Drug Design
  • Drug Discovery
  • Drug Resistance
  • Ductal Carcinoma In Situ
  • Duffy Antigen Receptor for Chemokines
  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging
  • Dysplasia
  • E
  • E T V6
  • E2A-PBX1
  • Early B-Cell Factors
  • Early Genes of Human Papillomaviruses
  • Early-Stage Ovarian Cancer
  • E-Box
  • E-Cadherin
  • Efferocytosis
  • Eicosanoids
  • Electromagnetic Fields
  • Electroporation
  • ELISA
  • Elongin BC Complex
  • Embryonic Stem Cells
  • Endocan
  • Endocrine Oncology
  • Endocrine Therapy
  • Endocrine Therapy in Breast Cancer
  • Endocrine-Related Cancers
  • Endocytosis
  • Endometrial Cancer
  • Endometrioma
  • Endoplasmic Reticulum Stress
  • Endosomal Compartments
  • Endostatin
  • Endothelial-Derived Gene-1
  • Endothelins
  • EpCAM
  • Eph Receptors
  • Epidemiology of Cancer
  • Epidermal Growth Factor Inhibitors
  • Epidermal Growth Factor Receptor
  • Epidermal Growth Factor-like Ligands
  • Epigallocatechin
  • Epigenetic
  • Epigenetic Biomarker
  • Epigenetic Gene Silencing
  • Epigenetic Modifications
  • Epigenetic Therapy
  • Epigenomics
  • Epithelial Tumorigenesis
  • Epithelial-to-Mesenchymal Transition
  • Epithelium
  • Epothilone B Analogue
  • Epothilones
  • Epstein-Barr Virus
  • Epstein–Barr Virus Latent Membrane Protein 1
  • Erlotinib
  • ERM Proteins
  • Erythroleukemia
  • Erythropoietin
  • E-Selectin-Mediated Adhesion and Extravasation in Cancer
  • Esophageal Adenocarcinoma
  • Esophageal Cancer
  • Estradiol
  • Estrogen Receptor
  • Estrogen Signaling
  • Estrogenic Hormones
  • Ether à-go-go Potassium Channels
  • Etidronate
  • Etoposide
  • Ets Transcription Factors
  • Everolimus
  • Ewing Sarcoma
  • EWS-FLI (ets) Fusion Transcripts
  • Exfoliation of Cells
  • Exosomal miRNA
  • Exosome
  • Extracellular Matrix Remodeling
  • Extracellular Signal-Regulated Kinases 1 and 2
  • Extrapulmonary Small Cell Cancer
  • F
  • Fanconi Anemia
  • Farnesylation
  • Fatty Acid Transport
  • FDG-PET
  • Fecal Immunochemical Test
  • Fecal Occult Blood Test
  • Fenretinide
  • Ferroptosis
  • Fever of Unknown Origin
  • Fibrinogen
  • Fibroblast Growth Factors
  • Fibronectin
  • Fibrosarcoma
  • Fibrosis and Cancer
  • Fibulins
  • Fine Needle Aspiration Biopsy
  • Firestorm Pattern
  • Flavonoids
  • FLICE-Inhibitory Protein
  • Flow Cytometry
  • FLT3
  • Fludarabine
  • Fluorescence Diagnostics
  • Fluorescence in Situ Hybridization
  • Fluorouracil
  • Fluoxetine
  • Focal Adhesion Kinase
  • Follicular Lymphoma
  • Follicular Thyroid Tumors
  • Follistatin
  • Food-Borne Carcinogens
  • Forkhead Box M1
  • Fragile Histidine Triad
  • Fragile Sites
  • Fucosylation
  • α1-6 Fucosyltransferase
  • Fucoxanthin
  • Fulvestrant
  • Fumarate Hydratase
  • Funnel Factors
  • Furin
  • Fusion Genes
  • G
  • G Proteins
  • G2/M Transition
  • GAGE Proteins
  • Gain-of-Function p53
  • Gallbladder Cancer
  • Gangliosides
  • Gankyrin
  • Gap Junctions
  • Gastric Cancer
  • Gastric Cancer Therapy
  • Gastrin
  • Gastrinoma
  • Gastrin-Releasing Peptide
  • Gastrointestinal Stromal Tumor
  • Gefitinib
  • Gelsolin
  • Gemcitabine
  • Gene Therapy
  • Genetic Toxicology
  • Genistein
  • Genomic Imbalance
  • Genomic Imprinting
  • Genomic Instability
  • Germinoma
  • Giant Cell Tumor
  • Ginkgo biloba
  • Gleason Grading
  • GLI Proteins
  • Glioblastoma Therapy
  • Glucose Metabolism
  • Glutathione Conjugate Transporter RLIP76
  • Glutathione S-Transferase
  • Glycobiology and Cancer
  • Glycosylation
  • Gonadotropin-Releasing Hormone
  • Good Laboratory Practices
  • Good Manufacturing Practices
  • Grading of Tumors
  • Graft Acceptance and Rejection
  • Granulosa Cell Tumors
  • Grape Seed Extract
  • Graves Disease
  • Green Tea Cancer Prevention
  • Growth Hormone-Releasing Hormone
  • GTPase
  • Gut Microbiota
  • Gut Peptides
  • Gynecomastia
  • H
  • γH2AX
  • Hairy Cell Leukemia
  • Hamartin
  • Haploinsufficiency
  • HB-EGF
  • HDAC Inhibitors
  • Head and Neck Cancer
  • Hedgehog Signaling
  • Helicobacter Pylori in the Pathogenesis of Gastric Cancer
  • Hematological Malignancies, Leukemias, and Lymphomas
  • Heparanase
  • Heparanase Inhibitors
  • Hepatic Epithelioid Hemangioendothelioma
  • Hepatic Ethanol Metabolism
  • Hepatitis B Virus
  • Hepatitis B Virus x Antigen-Associated Hepatocellular Carcinoma
  • Hepatitis C Virus
  • Hepatoblastoma
  • Hepatocellular Carcinoma
  • Hepatocellular Carcinoma Molecular Biology
  • Hepatocellular Carcinoma: Etiology, Risk Factors, and Prevention
  • HER-2/neu
  • Herceptin
  • Herpesvirus-Associated Ubiquitin-Specific Protease De-ubiquitinase
  • Heterochromatin
  • Heterocyclic Amines
  • Hexavalent Chromium
  • Hexokinase 2
  • Histocompatibility
  • Histocompatibility Antigens
  • Histone Acetyltransferases
  • Histone Modification
  • HLA Class I
  • Hodgkin and Reed/Sternberg Cell
  • Hodgkin Disease
  • Hodgkin Lymphoma, Clinical Oncology
  • Hollow Fiber Assay
  • Homeobox Genes
  • Homing Peptides and Vascular Zip Codes
  • Homologous Recombination Repair
  • Hormonal Carcinogenesis
  • Hormonal Therapy
  • Hormone Replacement Therapy
  • Hormone-Refractory Prostate Cancer
  • Hormones
  • HRAS
  • HSNF5/INI1/SMARCB1 Tumor Suppressor Gene
  • Hsp90
  • HSV-TK-/Ganciclovir-Mediated Toxicity
  • Human Herpesvirus 6
  • Human Papillomaviruses in Head and Neck Cancer
  • Human T-Lymphotropic Virus
  • Huntingtin Interacting Protein 1
  • HuR
  • Hurthle Cell Adenoma and Carcinoma
  • Hyaluronan Synthases
  • Hyaluronidase
  • Hydrogen Peroxide
  • 2-Hydroxyoleic Acid
  • Hypericin
  • Hyperplasia
  • Hyperthermia
  • Hypomethylation of DNA
  • Hypoxia
  • Hypoxia-Inducible Factor-1
  • I
  • IA4
  • IAP-3
  • IARC TP53 Database
  • ICF Syndrome
  • ICL670A
  • Idiopathic Myelofibrosis
  • Idiotype Vaccination
  • Idiotypic Vaccination
  • IDO
  • I-FLICE
  • iFOBT
  • IgE-Mediated Hypersensitivity
  • IHC
  • IL-6
  • ILP1
  • Imatinib
  • Imatinib (Gleevec)
  • Imatinib Mesylate
  • Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3, 4-dihydro-3-methyl-4-oxo-
  • Immediate Early Stress Response
  • Immune Escape
  • Immune Responses to Autoantigens
  • Immune-Mediated Suppression
  • Immunochemical Fecal Occult Blood Test
  • Immunocytochemistry
  • Immunoediting
  • Immunoglobulin Rearrangements
  • Immunohistochemistry
  • Immunohistology
  • Immunoliposomes
  • Immunological Fecal Occult Blood Test
  • Immunophenotypic Determinants
  • Immunoprevention
  • Immunoprophylaxis of Cancer
  • Immunoproteasome
  • Immunoreceptor
  • Immunosuppression and Cancer
  • Immunosurveillance of Tumors
  • Immunotherapy
  • Immunotoxins
  • Imprinting
  • In Situ Breast Cancer
  • In Situ Cancer
  • In Situ Carcinoma
  • In Utero Exposure to Carcinogenic Agents
  • In Vitro Bystander Effect
  • In Vitro Genetics
  • In Vivo Bystander Effect
  • Indirect Effect
  • Indirubin and Indirubin Derivatives
  • Individualized Treatment
  • Indoleamine 2,3-Dioxygenase
  • Induced Pluripotent Stem Cells
  • Induction Chemotherapy
  • Infiltration
  • Inflammation
  • Inflammatory Bowel Disease (also includes Ulcerative Colitis)-Related Cancer
  • Inflammatory Bowel Disease-Associated Cancer
  • Inflammatory Breast Cancer
  • Inflammatory Response and Immunity
  • Inflammosome
  • Infusion of T Cells
  • INHBA
  • INHBB
  • INHBC
  • INHBE
  • Inherited Human Polycystic Kidney Disease
  • Inhibin-β Chain
  • Inhibitor of FLICE
  • INK4A
  • Innate Immunity
  • Inositol Lipids
  • Insulin Receptor
  • Insulin Signaling
  • Insulin-Like Growth Factor (IGF) Signaling
  • Insulin-Like Growth Factors
  • Insulinoma
  • Integrated Positron Emission Tomography/Computed Tomography
  • Integrin Signaling
  • Integrin-Mediated Death
  • Interferon-Alpha
  • Interleukin-17
  • Interleukin-4
  • Interleukin-6
  • Intermediate Endpoint
  • Intermediate Junction
  • Intermediately or Poorly Differentiated Lymphocytic Lymphoma
  • Internalization
  • Interphase Cytogenetics
  • Intersectin
  • Interstitial Microinfusion
  • Intestinal Alkaline Phosphatase
  • Intestinal Metaplasia
  • Intestinal Organoids
  • Intestinal Sphere
  • Intracerebral Clysis
  • Intracerebral Microinfusion
  • Intraductal Carcinoma
  • Intraductal Papillary Mucinous Tumor
  • Intraocular Melanoma
  • Intrinsically Disordered Proteins
  • Intrinsically Unfolded Proteins
  • Intrinsically Unstructured Proteins
  • 3D In Vitro Culture
  • Invadosome
  • Invasion
  • Ion Channels
  • Ionizing Radiation (IR)-Induced Protein-8 (XIP-8)
  • Ionizing Radiation Therapy
  • Ionizing Radiation-Induced Cancer
  • IPL1
  • iPS Cells
  • iPSCs
  • IQ Motif-Containing GTPase-Activating Protein
  • IQGAP1 Protein
  • Irinotecan
  • Iron-Regulated Necrosis
  • Islet Cell Tumor
  • Islet Cell Tumors
  • Islet Cell Tumors (Pancreatic NET)
  • Isoflavones
  • (-)-1-Isothiocyanato-4(R)-(methylsulfinyl) Butane
  • Ixabepilone
  • J
  • J1 220/200
  • JAB1
  • Japanese Silver Apricot
  • Jasmonates in Cancer Therapy
  • Jelly Belly
  • JFY1
  • JmjC Domain-Containing Protein 3
  • JMJD3
  • JNK Subfamily
  • JNK1
  • JNK2
  • JNK3
  • Jumonji Domain-Containing Protein 3
  • Juvenile Type
  • K
  • Kallikreins
  • Kaplan-Meier Survival Analysis
  • Kaposi Sarcoma
  • KDM6
  • Kinetochore–Microtubule Interactions
  • KISS1
  • Kit/Stem Cell Factor Receptor in Oncogenesis
  • Klatskin Tumors
  • Klotho Tumor Suppressor
  • Knudson Hypothesis
  • Koch's Postulates
  • KRAS
  • KRAS in Colorectal Cancer Therapy
  • KSP Mitotic Spindle Motor Protein
  • Kupffer Cells
  • L
  • Lactoferricin Antiangiogenesis Inhibitor
  • Laminin Signaling
  • Langerhans Cell Histiocytosis
  • Large Cell Neuroendocrine Carcinoma
  • Laryngeal Carcinoma
  • Latency-Associated Nuclear Antigen (LANA)
  • Lats in Organ Size Regulation and Cancer
  • Lead Exposure
  • Lead Optimization
  • Leiomyosarcoma
  • Lentiviral Vectors
  • Leptomeningeal Dissemination
  • Leukemia Inhibitory Factor
  • Leukemia Stem Cells
  • Leukotrienes
  • Lewis Antigens
  • Leydig Cell Tumor
  • Li-Fraumeni Syndrome
  • LINE-1 Elements
  • Linkage Disequilibrium
  • Linoleic Acid
  • Lipid Mediators
  • Lipid Peroxidation
  • Lipid Raft
  • Lipocalin
  • Lipoma-Preferred Partner
  • Liposomal Chemotherapy
  • 5-Lipoxygenase
  • Live Cell Imaging
  • Lobular Involution of the Breast
  • Locoregional Therapy
  • Log-Kill Hypothesis
  • LPA
  • Luciferase Reporter Gene Assays
  • Lugol-Unstained Lesion
  • Lunasin
  • Lung Cancer
  • Lung Cancer and Smoking Behavior
  • Lung Cancer Clinical Oncology
  • Lung Cancer Epidemiology
  • Lung Cancer Pharmacogenomics
  • Lung Cancer Staging
  • Lung Cancer Targeted Therapy
  • Lymphadenectomy
  • Lymphangiogenesis
  • Lymphatic Vessels
  • Lynch Syndrome
  • Lysophosphatidylcholine
  • M
  • Macrophages
  • Macrophage-Stimulating Protein
  • MAGE-A11
  • Maintenance Chemotherapy
  • Major Vault Protein
  • Male Breast Cancer
  • Malignancy-Associated Changes
  • Malignant Lymphoma: Hallmarks and Concepts
  • MALT Lymphoma
  • Mammalian Target of Rapamycin
  • MammaPrint Test
  • Mammographic Breast Density and Cancer Risk
  • Mammographic Density
  • Mantle Cell Lymphoma
  • MAP Kinase
  • Marginal Zone B-Cell Lymphoma
  • Maspin
  • Mast Cells
  • Mastocytosis
  • Matrix Metalloproteinases
  • Mcl Family
  • Mcl-1
  • MCT-1 Oncogene
  • MDM Genes
  • MDM2
  • Medullary Thyroid Cancer Targeted Therapy
  • Melanocytic Tumors
  • Melanoma Antigens
  • Melanoma Drug Treatment
  • Melanoma Vaccines
  • Melanoma-Associated Retinopathy
  • Melatonin
  • Membrane Transporters
  • Membrane-Linked Docking Protein
  • Membrane-Lipid Therapy
  • Menopausal Symptoms After Breast Cancer Therapy
  • Merlin
  • Mesenchymal Stem Cells
  • Mesoblastic Nephroma
  • Mesothelin
  • Mesothelioma
  • MET
  • Meta-Analysis
  • Metabolic Polymorphisms and Cancer Susceptibility
  • Metabolic Reprogramming
  • Metal Drugs
  • Metastasis
  • Metastasis Suppressor Gene
  • Metastasis Suppressor KAI1/CD82
  • Metastatic Breast Cancer Experimental Therapeutics
  • Metastatic Colonization
  • Methoxyestradiol
  • Methylation
  • Methylation-Controlled J Protein
  • Methyltransferases
  • Metronomic Chemotherapy
  • MIC Molecules
  • MIC-1
  • Microarray (cDNA) Technology
  • Microcell-Mediated Chromosome Transfer
  • Microcystin-LR
  • Micrometastasis
  • Micronucleus Assay
  • MicroRNA
  • Microsatellite Instability
  • Microtubule-Associated Proteins
  • Migration
  • Mineral Nutrients
  • Minimal Residual Disease
  • Minodronate
  • Mismatch Repair in Genetic Instability
  • Mitochondrial DNA
  • Mitochondrial Membrane Permeabilization in Apoptosis
  • Mitogen-Activated Protein Kinase Kinase Kinases
  • Mitogen-Inducible Gene 6 in Cancer
  • Mitomycin C
  • Mitotic Arrest-Deficient Protein 1
  • Mitotic Catastrophe
  • Modifier Loci
  • Modular Transporters
  • Molecular Chaperones
  • Molecular Imaging
  • Molecular Pathology
  • Molecular Therapy
  • Monoclonal Antibodies for Cancer Therapy
  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
  • Motility
  • Mouse Models
  • mRNA Translation
  • Mucins
  • Mucoepidermoid Cancer
  • Multigene Array
  • Multiple Endocrine Neoplasia Type 1
  • Multiple Myeloma
  • Multistep Development
  • Mutagen Sensitivity
  • Mutation Rate
  • Mutator Phenotype
  • MUTYH-Associated Colorectal Polyposis
  • MYB
  • MYC Oncogene
  • Myeloablative Megatherapy
  • Myelodysplastic Syndromes
  • Myelosuppression
  • Myopodin
  • Myxoid Liposarcoma
  • N
  • N-(4-hydroxyphenyl)retinamide
  • NA1/NA2
  • NAALADase
  • NAB
  • NaCHOleate
  • NAD-Dependent Deacetylase Sirtuin-1
  • Naevoid Basal Cell Carcinoma Syndrome
  • NAG-1
  • NAME
  • Nanocapsules
  • Nanoformulations
  • Nanomedicine
  • Nanoparticles
  • Nanoparticles in Cancer Therapy
  • Nanoparticles in Diagnosis and Treatment
  • Nanospheres
  • Nanotechnology
  • Nasopharyngeal Carcinoma
  • NAT
  • Natural Immunity
  • Natural Killer Cell Activation
  • Natural Killer Group 2D
  • Natural Products
  • Natural Yellow 3
  • Naturally Disordered Proteins
  • Naturally Unfolded Proteins
  • Naturally Unstructured Proteins
  • NBCCS
  • NBK (Natural Born Killer)
  • NCA-160
  • NCI60_003316
  • NCoA3
  • ncRNA
  • Necroptosis
  • Necrosis
  • Needle Aspiration Biopsy
  • Needle Biopsy
  • Nek2
  • Nemosis
  • Neoadjuvant Chemotherapy (Neoadjuvant Therapy)
  • Neoadjuvant Therapy
  • Neoplastic Meningitis
  • Neovascularization
  • Nephroblastoma
  • Nestin
  • NET
  • Neuroblastoma
  • Neurocytoma
  • Neuroectodermal Tumor
  • Neuroendocrine Carcinoma
  • Neuroendocrine Neoplasms
  • Neuroendocrine Tumors of the Pancreas
  • Neuroepithelioma
  • Neurofibromatosis 1
  • Neurofibromatosis 2
  • Neurokinins
  • Neuromedin
  • Neuronectin
  • Neuron-Restrictive Silencer Factor (NRSF)
  • Neuro-oncology: Primary CNS Tumors
  • Neuropathy
  • Neuropeptides
  • Neuropilin Ligands
  • Neuroprotection
  • Neurotrophic Factors
  • Neurotrophins
  • Neutropenia
  • Neutrophil Elastase
  • Neutrophil Elastase 2
  • Neutrophil Expressed (ELANE as the official gene symbol)
  • Nevi
  • Nevocellular Nevus
  • Nevus
  • New York Esophageal Squamous Cell Carcinoma 1
  • Nexavar
  • NF1
  • NF2
  • NF2 Gene Product
  • NF-κB
  • NGF Family
  • NGRD2
  • Nickel Carcinogenesis
  • Nickel Tumorigenesis
  • Nickel-Induced Cell Transformation
  • Nicotine Addiction
  • Nicotine Dependence
  • Nijmegen Breakage Syndrome
  • Nilotinib
  • Nitric Oxide
  • Nitrogen-Containing Bisphosphonate
  • NK Cell Induction
  • NK Cell Stimulation
  • NKG2D
  • NKG2D Receptor
  • N-myc Downstream-Regulated Gene
  • N-myc Downstream-Regulated Gene, NDRG1
  • Nodularin
  • Nonclassical Apoptosis
  • Noncoding RNA
  • Noninvasive breast Cancer
  • Nonprimary APC Mutation Colorectal Cancer
  • Non-Rhabdomyosarcoma Soft Tissue Sarcomas
  • Non-Seminomatous Germ Cell Tumor
  • Non-Small-Cell Lung Cancer
  • Nonspecific Cross-Reacting Antigen with a Mw of 160kD
  • Nonsteroidal Anti-inflammatory Drugs
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • Nontargeted Effect
  • Non-Targeted Effects
  • Nonviral Vector for Cancer Therapy
  • Norton-Simon Hypothesis
  • Notch/Jagged Signaling
  • NPC
  • NPP2
  • NR1C
  • NR1I3
  • NR3C4
  • NRSTS
  • NS3
  • NSC-10514-F
  • NSC-312887
  • NSC362856
  • NSC-638850
  • NSC-684766
  • NSC-710428
  • Nuclear Factor-KappaB
  • Nuclear Factor-κB
  • Nuclear Receptor Coactivator 3
  • Nuclear Receptor Subfamily 1, Group I, Member 2 (NR1I2)
  • Nuclear Receptors
  • Nucleic Acid-Based Biomarkers
  • Nucleolin
  • Nucleoporin
  • Nucleosome Remodeling
  • Nucleotide Excision Repair
  • NUP98-HOXA9 Fusion
  • NUPR1
  • Nutraceuticals
  • Nutrition Status
  • Nutritional Factors
  • Nutritional Prevention of Colon Cancer
  • NY ESO 1
  • NY-ESO-1
  • O
  • Obesity and Cancer Risk
  • Okadaic Acid
  • Oligoastrocytomas
  • Oligodendroglioma
  • Omental Immune Aggregates
  • OncoArray
  • Oncofetal Antigen
  • Oncogene
  • Oncogene Addiction
  • Oncology Models in Mice
  • Oncolytic Adenovirus
  • Oncolytic Virus
  • Oncopeptidomics
  • Oncoplastic Surgery
  • Oncostatin M
  • Oncotype DX
  • Optimal Treatment for Women with Ovarian Cancer
  • Oral Cancer
  • Orphan Nuclear Receptors
  • Osteoblastic Bone Lesion
  • Osteochondroma
  • Osteoclast
  • Osteolysis
  • Osteopontin
  • Osteoporosis
  • Osteosarcoma
  • Ovarian Cancer
  • Ovarian Cancer Chemoresistance
  • Ovarian Cancer Chemotherapy
  • Ovarian Cancer Clinical Oncology
  • Ovarian Cancer Drug Resistance
  • Ovarian Cancer Epidemiology
  • Ovarian Cancer Hormonal Therapy
  • Ovarian Cancer Immunotherapy
  • Ovarian Cancer Pathology
  • Ovarian Cancer Stem Cells
  • Ovarian Germ Cell Tumors
  • Ovarian Mucinous Carcinoma
  • Ovarian Serous Carcinoma
  • Ovarian Small Cell Carcinoma Hypercalcemic Type
  • Ovarian Stromal and Germ Cell Tumors
  • Ovarian Tumors During Childhood and Adolescence
  • Oxidative Stress
  • Oxygen Sensing
  • Oxygenation of Tumors
  • P
  • p21
  • p27
  • p53 Family
  • P8 Protein
  • Paclitaxel
  • Palladium-Based Anti-Cancer Therapeutics
  • Palliative Therapy
  • Pancreatic Cancer
  • Pancreatic Cancer Basic and Clinical Parameters
  • Pancreatic Cancer Biology and Management
  • Pancreatic Cancer Biomarkers
  • Pancreatic Cancer Desmoplastic Reaction and Metastasis
  • Pancreatic Cancer Development and Regeneration
  • Pancreatic Cancer Metastasis
  • Pancreatic Cancer Pathogenesis
  • Pancreatic Cancer Stem Cells
  • Pancreatic Cancer Molecular Targets for Therapy
  • Pancreatitis
  • Pannexins
  • Papanicolaou Test
  • Papillary Thyroid Carcinoma
  • PARAHOX
  • Parathyroid Hormone-Related Protein
  • PARP Inhibitors
  • Particle-Induced Cancer
  • Pathology
  • Paxillin
  • PCA3
  • PDT-Induced Apoptosis
  • Pediatric Brain Tumors
  • Pediatric HIV/AIDS
  • Pemetrexed
  • Pentakisphosphate
  • Peptide Biomarkers
  • Peptide Vaccines for Cancer
  • Peptidylarginine Deiminase Enzymes
  • Periostin
  • Peripheral Neuropathy
  • Peroxisome Proliferator-Activated Receptor
  • Personalized Cancer Medicine
  • Peutz–Jeghers Syndrome
  • P-Glycoprotein
  • Phage Display
  • Pharmacogenomics in Multidrug Resistance
  • Pharmacokinetics and Pharmacodynamics in Drug Development
  • Pharmacophore
  • Phase II Enzymes
  • Pheochromocytoma
  • Phosphatase
  • Phospholipase A2
  • Phospholipase D
  • Photocarcinogenesis
  • Photochemoprevention
  • Photodynamic Therapy
  • Photo-Induced DNA Damage
  • Photothermal Therapy
  • Phytochemicals in Cancer Prevention
  • Phytoestrogens
  • PI3K Signaling
  • PICALM
  • PIK3CA
  • PIM Protein Kinase Family
  • Placenta Growth Factor
  • Placental Site Trophoblastic Tumor
  • Plasmacytoma
  • Plasminogen-Activating System
  • Platelet
  • Platelet-Activating-Factor
  • Platelet-Derived Growth Factor
  • Platinum Complexes
  • Platinum-Refractory Testicular Germ Cell Tumors
  • Pleiotrophin
  • Pleural Effusion
  • Plexins
  • Podoplanin
  • POEMS Syndrome
  • Poly(ADP-Ribosyl)ation
  • Polyamines
  • Polycomb Group
  • Polycyclic Aromatic Hydrocarbons
  • Polycystic Kidney Disease
  • Polycythemia
  • Polyphenols
  • Polyunsaturated Fatty Acids
  • Positron Emission Tomography
  • Preclinical Testing
  • Pre-mRNA Splicing
  • Preneoplastic Lesions
  • Presenilin
  • Primary Myelofibrosis
  • Probiotics and Cancer
  • Progestin
  • Programmed Cell Death 4
  • Progression
  • Prolactin
  • Prostaglandins
  • Prostate Cancer
  • Prostate Cancer Chemotherapy
  • Prostate Cancer Clinical Oncology
  • Prostate Cancer Diagnosis
  • Prostate Cancer Epidemiology
  • Prostate Cancer Experimental Therapeutics
  • Prostate Cancer Genetic Toxicology
  • Prostate Cancer Hormonal Therapy
  • Prostate Cancer Molecularly Targeted Therapies
  • Prostate Cancer Prevention
  • Prostate Cancer Radionuclide Imaging
  • Prostate Cancer Radionuclide Therapy
  • Prostate Cancer Stem Cells
  • Prostate Cancer Targeted Therapy
  • Prostate-Specific Antigen
  • Prostate-Specific Membrane Antigen
  • Protease-Activated Receptor Family
  • Protease-Activated Receptors
  • Proteasome
  • Proteasome Inhibitors
  • Protein Kinase C Family
  • Protein Kinases
  • Proteinase-Activated Receptor-1
  • Proteinase-Activated Receptor-2
  • Proteinase-Activated Receptor-3
  • Proteinase-Activated Receptor-4
  • Proteinchip
  • 14-3-3 Proteins
  • Proteomics
  • Proton Beam Therapy
  • Prune
  • Pseudomyxoma Peritonei
  • PUMA
  • Pyroptosis
  • Q
  • Quantitative Structure Activity Relationship
  • R
  • Radiation Carcinogenesis
  • Radiation Oncology
  • Radiation Sensitivity
  • Radiation-Induced Sarcomas After Radiotherapy
  • Radioimmunotherapy
  • Radiological Response Criteria
  • Radioprotectors
  • Radiosensitization
  • Radiosensitizer
  • Radon
  • Raf Kinase
  • RANK–RANKL Signaling
  • Rap1 and Sipa-1
  • Rapamycin
  • RAS Activation
  • RAS-Association Domain Family 1
  • RAS Genes
  • RAS Transformation Targets
  • RE1-Silencing Transcription Factor
  • Reactive Oxygen Species
  • Receptor Cross-Talk
  • Receptor Tyrosine Kinase Inhibitors
  • Receptor Tyrosine Kinases
  • Receptors
  • RECK Glycoprotein
  • Recombinant Therapeutics
  • Rectal Cancer
  • Reductases
  • Regeneration
  • Regorafenib
  • Regulatory T Cells
  • Rel
  • Relaxin
  • Renal Cancer Clinical Oncology
  • Renal Cancer Diagnosis
  • Renal Cancer Genetic Syndromes
  • Renal Cancer Molecular Therapy
  • Renal Cancer Pathogenesis
  • Renal Cancer Targeted Therapies with Tyrosine Kinase Inhibitors
  • Renal Cancer Therapy
  • Renal Cancer Treatment
  • Renal Cancer Trends in Molecularly Targeted Therapies
  • Repair of DNA
  • Replication Factories and Replication Foci
  • Resistin
  • Restriction Landmark Genomic Scanning
  • Resveratrol
  • RET
  • Retinoblastoma
  • Retinoblastoma Protein, Biological and Clinical Functions
  • Retinoblastoma Protein, Cellular Biochemistry
  • Retinoic Acid
  • Retinoid Receptor Cross-Talk
  • Retinoids
  • Retroviral Insertional Mutagenesis
  • Rhabdoid Tumor
  • Rhabdomyosarcoma
  • Rho Family Proteins
  • Ribosome-Inactivating Proteins
  • Rituximab
  • RNA Interference
  • RNA Polymerase I Transcription
  • Ron Receptor
  • Runx1
  • S
  • S(1–5), T16, EFEMP1, FBLN-3
  • S-100 Proteins
  • SAAB
  • SAC
  • SAHA
  • Salicylate
  • Salisburia adiantifolia
  • Salisburia macrophylla
  • Salivary agglutinin (SAG, Human)
  • Salivary Gland Malignancies
  • Salt Intake
  • Salting
  • SAPKα
  • SAPKβ
  • SAPKγ
  • Saporin
  • Scaffold Proteins
  • Scatter Factor
  • SCF Receptor
  • SCF-R
  • SCGE
  • SCH52365
  • Schwannoma-Derived Growth Factor
  • Schwannomin
  • Scirrhous
  • Sclerosing Angiogenic Tumor
  • Sclerosing Endothelial Tumor
  • Sclerosing Epithelioid Angiosarcoma
  • Sclerosing Interstitial Vascular Sarcoma
  • Sclerosing Stromal Cell Tumor
  • SDF-1α
  • SDGF
  • Sdi1
  • Second Malignant Neoplasm SMN
  • Second Primary Cancer SPC
  • Second Primary Cancers
  • Second Primary Malignancy SPM
  • Second Primary Tumors
  • Secondary Metabolites
  • Secondary Tumor
  • Secretagogues
  • γ-Secretase
  • Secreted Phosphoprotein 1
  • Secreted Protein Acidic and Rich in Cysteine
  • Securin
  • “Seed and Soil” Theory of Metastasis
  • SEL-12
  • Selective Effect
  • Selective Serotonin Reuptake Inhibitors
  • Selenium
  • SELEX
  • SEMA
  • Semanová II Syndrome
  • Semaphorin
  • Semaphorin Receptors
  • Semaxanib (SU5416)
  • Seminoma
  • Seminomatous Germ Cell Tumor
  • Senescence and Immortalization
  • Senescence-Associated Chronic Inflammation
  • Senile Involution
  • Sentinel Lymph Node
  • Sentinel Node
  • SEREX
  • Serine Elastase
  • Serine Protease Inhibitor-Like Domain
  • Serine Proteases (Type II) Spanning the Plasma Membrane
  • Serine-Threonine Kinase Receptor-Associated Protein
  • Sertoli-Leydig Cell Tumor
  • Serum Biomarkers
  • Seven in Absentia Homologue
  • Severe Hypoxia
  • Sex Cord-Stromal Tumors – Granulosa Cell Tumors
  • Sex Cord-Stromal Tumors with Annular Tubules
  • Sezary Syndrome
  • SH2/SH3 Domains
  • SH2/Src Homology 3
  • SH3 Domains
  • SH3p17
  • SH3p18
  • SH3P9
  • Shark Cartilage
  • Shedding of Cells
  • Short Hairpin RNA
  • shRNA
  • SIAH
  • Sicca Complex
  • Sicca Syndrome
  • Side Population Cells
  • Signal Transducer and Activator of Transcription
  • Signal Transducer and Activator of Transcription 3
  • Signal Transducers and Activators of Transcription in Oncogenesis
  • Signal Transduction
  • Signal Transduction Inhibitor-571
  • Silent Mating Type Information Regulation 2 Homolog 1
  • SIMA135 (Subtractive Immunization M(+)HEp3 Associated 135 kDa Protein)
  • Simian Virus 40
  • Single-Cell Gel Electrophoresis Assay
  • Single-Cell Microgel Electrophoresis Assay
  • Single-Chain Fv Dimer
  • SIR2L1
  • SiRNA
  • siRNA
  • Sirolimus
  • SIRT1
  • Sirtuin 1
  • Site-Specific Drug Delivery
  • Sivelestat
  • Sjögren Syndrome
  • Skeletal Complications (Skeletal-Related Events)
  • Skeletal Metastasis
  • Skeletal Secondary Tumors
  • Skeletrophin
  • SKI390
  • Skin Cancer
  • Skin Carcinogenesis
  • Skinny Needle
  • Skipper-Schabel Model
  • Skipper-Schabel-Wilcox Model
  • Skp2
  • SL-1
  • Slit
  • Sloughing of Cells
  • SM-5887
  • SMA- and MAD-Related Protein 4
  • Smad Proteins in TGF-Beta Signaling
  • SMAD4
  • Small Cell and Large Cell Neuroendocrine Carcinomas (NEC) at the Highly Aggressive Pole of the Spectrum of NENs
  • Small Cell Lung Cancer
  • Small Cell Neuroendocrine Carcinoma
  • Small Cleaved Cell Lymphoma
  • Small GTP-Binding Proteins
  • Small Interfering RNA
  • Small Molecule Drugs
  • Small Molecule Screens
  • Small Round Cell Tumor
  • SMARCB1
  • SMAX1
  • SMR
  • Snail Transcription Factors
  • SOCS
  • Sodium Chloride
  • Soft Tissue Sarcoma
  • Solar Light-Induced Cancer
  • Soluble ATP-Dependent Non-Lysosomal Proteolytic System
  • Soluble Mesothelin-Related Proteins
  • Somatic Recombination of V, D, and J Segments
  • Somatic Stem Cells
  • Somatocrinin
  • Somatoliberin
  • Somites
  • Sonochemotherapy
  • Sonodynamic Therapy
  • Sorafenib
  • Sorafenib (Nexavar)
  • Sorafenib [INN]
  • Sorafenibum
  • Soy Phytoestrogen
  • SPARC
  • Spasmolytic Polypeptide SP/TFF2
  • SPB
  • SPC1
  • Specific Immunotherapy for Melanoma
  • Spectral Karyotyping
  • Sphacelus
  • S-Phase Damage-Sensing Checkpoints
  • S-Phase-Kinase-Associated Protein 2
  • Sphingolipid Metabolism
  • Spinal and Bulber Muscular Atrophy (SBMA)
  • Spindle Assembly Checkpoint
  • Spindle Pole Body
  • Spinesin (TMPRSS5)
  • Spleen Tyrosine Kinase
  • Sprouty
  • Spry
  • Squamous Cell Carcinoma
  • Src
  • Src Homology 2
  • SRC-1: NCOA1
  • SRC-2: NCOA2
  • SRC-3
  • SRC-3: NCOA3
  • Src8
  • SSRIs
  • Stage IA–C Ovarian Cancer
  • Staging of Tumors
  • STARD12
  • START Domain-Containing Protein
  • STAT
  • STAT3
  • Staurosporine
  • Steel Ligand Receptor
  • Stefins
  • Stem Cell Factor
  • Stem Cell Imaging
  • Stem Cell Markers
  • Stem Cell Mobilization
  • Stem Cell Plasticity
  • Stem Cell Telomeres
  • Stem-Like Cancer Cells
  • Steroid Receptor Coactivator-3
  • Steroid Receptor Coactivators
  • Steroid Receptor Coactivators (SRCs): Nuclear Receptor Coactivators (NCOAs)
  • Steroid Sulfatase
  • Steroid Sulfohydrolase
  • Steroid Tumor
  • Steroid X Receptor (SXR)
  • Steryl Sulfohydrolase
  • STI571
  • STI-571
  • Sticker Sarcoma
  • Stivarga
  • STK12
  • STK13
  • STK15
  • STK5
  • STK6
  • STK7
  • STMY1
  • Stomach Cancer
  • STR1
  • STRAP
  • Stress
  • Stress Response
  • Stress-Activated Protein Kinase
  • Stress-Induced Bystander Effect
  • Stroma
  • Stromagenesis
  • Stromal Cell Response
  • Stromal Progression
  • Stromatogenesis
  • Stromelysin-1
  • Structural Biology
  • Structural Vascular Stabilization
  • STS
  • Subarachnoidal Spread
  • Subependymal Giant Cell Astrocytoma
  • Suberoylanilide Hydroxamic Acid
  • Substrate Channeling
  • Subtype AML-M7
  • Suicide Gene Therapy
  • Sulfated Glycoprotein-2 (SGP-2)
  • Sulfokinases
  • Sulforaphane
  • Sulfotransferases
  • Sunitinib (Sutent)
  • Sunlight-Induced Cancer
  • Supervised Classification
  • Supervised Learning
  • Supportive Care
  • Suppressive T Cells
  • Suppressor of Invasion, Metastasis, and Angiogenesis
  • Suppressors of Cytokine Signaling
  • Surface Molecules
  • Surface Plasmon Resonance
  • Surgical Pathology
  • Surgical Trauma and Cancer Recurrence
  • Surrogate Endpoint
  • Surrogate Endpoint Biomarker
  • Surrogate Outcome
  • Survivin
  • Susceptibility Loci
  • SV40
  • SWI/SNF-Related, Matrix-Associated, Actin-Dependent Regulator of Chromatin Subfamily b, Member 1
  • Syk
  • Syk Tyrosine Kinase
  • SYLD (syld709613 Protein)
  • Synovial Sarcoma
  • Synthetic Cannabinoids
  • Synuclein
  • Systemic Antibody-Directed Radionuclide Therapy
  • Systemic Spread of Cancer
  • Systemic Therapy
  • T
  • T-Cell Response
  • Tachykinins
  • Tamoxifen
  • Tankyrases
  • Targeted Drug Delivery
  • Targeting Cancer Stem Cells
  • TAT Protein of HIV
  • Taxol
  • Taxotere
  • TCL1
  • Technical Knockout
  • Telomerase
  • Temozolomide
  • Temsirolimus
  • Tenascin-C
  • Tensional Homeostasis
  • Testicular Cancer
  • Testicular Germ Cell Tumors
  • Theranostics
  • Thiazolidin
  • Thioredoxin System
  • Three-Dimensional Culture
  • Three-Dimensional Tissue Cultures
  • Thrombospondin
  • Thymidine Phosphorylase
  • Thymoma
  • Thyroid Cancer Treatment
  • Thyroid Carcinogenesis
  • Tiam1
  • Tight Junction
  • Time of Flight
  • Time-Resolved Fluorescence Resonance Energy Transfer Technology in Drug Discovery
  • Tissue Inhibitors of Metalloproteinases
  • Tissue Stem Cells
  • TLR4
  • TMPRSS2/ERG Fusions
  • TNF-Related Apoptosis-Inducing Ligand
  • TNF-α in HIV Infection
  • Tobacco Carcinogenesis
  • Tobacco-Related Cancers
  • Toll-Like Receptors
  • Tongue Cancer
  • Topoisomerases
  • Toxicogenomics
  • Toxicological Carcinogenesis
  • TP53
  • Trabectedin
  • TRAIL Receptor Antibodies
  • Transcoelomic Metastasis
  • Transduction of Oncogenes
  • Transforming Growth Factor-Beta
  • Transgenic Mouse
  • Transglutaminase-2
  • Transitional Cell Carcinoma
  • Translesion DNA Polymerases
  • Transplacental Carcinogenesis
  • Trastuzumab
  • Trefoil Factors
  • Triple-Negative Breast Cancer
  • Trophectoderm
  • Tuberous Sclerosis Complex
  • Tumor Antigens
  • Tumor Cell-Induced Platelet Aggregation
  • Tumor Microenvironment
  • Tumor Necrosis Factor
  • Tumor Suppression
  • Tumor Suppressor Genes
  • Tumor-Associated Macrophages
  • Tumor–Endothelial Cross-Talk
  • Tunicamycin
  • Turcot Syndrome
  • Tyrosine Kinase Inhibitors
  • U
  • Ubiquitin Ligase SCF-Skp2
  • Ubiquitination
  • UCN-01 Anticancer Drug
  • Ultrasound Microimaging
  • Uncertain or Unknown Histogenesis Tumors
  • Unfolded Protein Response and Cancer
  • Uranium Miners
  • Urokinase-Type Plasminogen Activator
  • Urothelial Carcinoma
  • Urothelial Carcinoma, Clinical Oncology
  • Uterine Leiomyoma
  • Uterine Leiomyoma, Clinical Oncology
  • UTX
  • UV Radiation
  • Uveal Melanoma
  • V
  • V(D)J Recombination
  • Valproic Acid
  • Vanadium
  • Vascular Disrupting Agents
  • Vascular Endothelial Growth Factor
  • Vascular Stabilization
  • Vascular Targeting Agents
  • Vasculogenic Mimicry
  • Vasopressin
  • Villi
  • Viral Oncology Epigenetics
  • Viral Vector-Mediated Gene Transfer
  • Virology
  • Virotherapy
  • Vitamin D
  • Von Hippel-Lindau Disease
  • Von Hippel-Lindau Tumor Suppressor Gene
  • Vorinostat
  • W
  • Warburg Effect
  • Wilms’ Tumor
  • WIPI
  • Withaferin A
  • Wnt Signaling
  • WWOX
  • X
  • Xenobiotics
  • Xeroderma Pigmentosum
  • XIAP
  • Xiphophorus
  • Z
  • Z-Factor
  • Zoledronic Acid
  • Zonula Occludens Protein-1